Key result
Higher flavonoid intake is linked to reduced CHD mortality and incident stroke across prospective cohorts.
Systematic Review
Yes
p-value: p=< 0.05
Twenty publications from twelve prospective cohorts have evaluated associations between flavonoid intakes and incidence or mortality from cardiovascular disease (CVD) among adults in Europe and the United States. The most common outcome was coronary heart disease mortality, and four of eight cohort studies reported significant inverse associations for at least one flavonoid class (multivariate adjusted p(trend) < 0.05). Three of seven cohorts reported that greater flavonoid intake was associated with lower risk of incident stroke. Comparisons among the studies were difficult because of variability in the flavonoid classes included, demographic characteristics of the populations, outcomes assessed, and length of follow-up. The most commonly examined flavonoid classes were flavonols and flavones combined (11 studies). Only one study examined all seven flavonoid classes. The flavonol and flavone classes were most strongly associated with lower coronary heart disease mortality. Evidence for protection from other flavonoid classes and CVD outcomes was more limited. The hypothesis that flavonoid intakes are associated with lower CVD incidence and mortality requires further study.
No takes yet. Share an insight, caveat, or question.
Peterson et al. (2012) conducted a systematic review in Cardiovascular disease. Flavonoid intake vs. Lower flavonoid intake was evaluated on Coronary heart disease mortality (p=< 0.05). Greater flavonoid intake, particularly flavonols and flavones, was significantly associated with lower coronary heart disease mortality and incident stroke across multiple prospective cohorts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: